Researchers have lab-tested a molecule that can combat the common cold virus by preventing it from hijacking human cells.
Early lab-based tests with human cells have shown the molecule’s ability to completely block multiple strains of cold virus, and the team hope to move to animal and then human trials. The results of initial tests are published today in the journal Nature Chemistry.
A drug like this could be extremely beneficial if given early in infection, and we are working on making a version that could be inhaled, so that it gets to the lungs quickly.Professor Ed Tate
The common cold is caused by a family of viruses with hundreds of variants, making it nearly impossible to become immune to or vaccinate against all of them. On top of that, the viruses evolve rapidly, meaning they can quickly gain resistance to drugs.
For these reasons, most cold remedies rely on treating the symptoms of the infection – such as runny nose, sore throat and fever – rather than tackling the virus itself.
However a new molecule, developed by researchers at Imperial College London, targets N-myristoyltransferase (NMT), a protein in human cells. Viruses ‘hijack’ NMT from human cells to construct the protein ‘shell’, or capsid, which protects the virus genome.
All strains of the virus need this same human protein to make new copies of themselves, so the molecule should work against all of them. Additionally, the molecule also works against viruses related to the cold virus, such as polio and foot and mouth disease viruses.
More than just an inconvenience
The molecule targets a human protein and not the virus itself, making emergence of resistant viruses highly unlikely.
Lead researcher Professor Ed Tate, from the Department of Chemistry at Imperial, said: “The common cold is an inconvenience for most of us, but can cause serious complications in people with conditions like asthma and COPD.
“A drug like this could be extremely beneficial if given early in infection, and we are working on making a version that could be inhaled, so that it gets to the lungs quickly.”
There have been previous attempts to create drugs that target human cells rather than the viruses, but many have the side effect of being toxic. The researchers showed that the new molecule completely blocked several strains of the virus without affecting human cells. Further study is needed to make sure it is not toxic in the body.
The common cold, via malaria and Viagra
The research team included the labs of Professor Roberto Solari and Professor Seb Johnston at Imperial’s National Heart & Lung Institute, Dr Aurelie Mousnier from Imperial and Queen’s University Belfast, structural biologists at the University of York, and colleagues at the Pirbright Institute.
Professor Tate said: “The way the drug works means that we would need to be sure it was being used against the cold virus, and not similar conditions with different causes, to minimise the chance of toxic side effects.”
The medicinal chemistry team in the Tate group at Imperial, led by Dr Andy Bell (who previously invented Viagra as a researcher at Pfizer), were originally looking for compounds that targeted the protein in malaria parasites. Screening large libraries of compounds, they found two hits and were surprised to discover that they worked best together.
By inventing a novel way to combine the two, they created a molecule, codenamed IMP-1088, which is more than a hundred times more potent than previous molecules targeting the protein in humans.
The Latest on: Common cold
via Google News
The Latest on: Common cold
- 12 Signs Your Common Cold Could Be Something Way Worse on October 2, 2018 at 9:13 am
Anyone who says “it’s just a cold” is forgetting exactly how miserable the virus can be: Runny nose, sore throat, headaches, fatigue, sneezes—and those are just a few of the nasty symptoms, explains M... […]
- What This 94-Year-Old Doctor Eats Every Day to Avoid the Common Cold and Flu on October 2, 2018 at 6:30 am
Long after most people would have retired, Murray Grossan, 94, still works as an otolaryngologist (ear, nose and throat doctor) at the Grossan Institute in Los Angeles, California. Every day, he’s aro... […]
- Beat the bug before it beats you: how to prevent and fight the common cold on October 1, 2018 at 9:11 pm
Students at Iowa State are exposed to coughs and sneezes from classmates, which also means they are exposed to the danger of catching contagious germs, viruses and bacteria. Health specialists from CV... […]
- Enzymatica AB: Significant benefits from ColdZyme in a major German multicenter study evaluating different common cold symptom scales on September 30, 2018 at 11:31 pm
Preliminary analysis of the Enzy-003 study on naturally occuring common cold, shows a significant reduction of disease duration and symptoms with ColdZyme usage, and less use of concomitant ... […]
- The Common Cold of Anxiety on September 29, 2018 at 5:00 pm
Generalized Anxiety Disorder (GAD) is the most common form of anxiety affecting more people around the world than any other type of anxiety. People with GAD report a mix of symptoms–physical sensation... […]
- Chicken soup for the common cold on September 28, 2018 at 5:00 pm
Your grandmother was right. No, not about going blind if you sit too close to the TV. She was right about eating chicken soup when you’re sick. Science has proven, at least preliminarily, that ingesti... […]
- Centaur Pharmaceuticals Celebrates 'Anti-cold Day' and Concludes the 10th 'Common Cold Awareness Week' Campaign on September 28, 2018 at 4:30 am
Centaur Pharmaceuticals, the leaders in the anti-cold segment, recently conducted the 'Common Cold Awareness Week', a nation-wide campaign from September 10 th to 15 th, 2018 to mark 'Anti-cold Day' o... […]
- DuPont study not to be sniffed at as nasal microbiota linked to strength of common cold on September 27, 2018 at 7:20 am
The nasal microbiota could form the starting point for addressing the symptoms of the common cold, according to a collaborative clinical study involving DuPont Nutrition & Health. Findings from the st... […]
- Doctors warned against mistaking H1N1 symptoms for common cold on September 26, 2018 at 4:12 pm
AHMEDABAD: As the number of swine flu cases in Gujarat surges, state health authorities have now warned private general practitioners against writing off fever, sore throats and running noses as ... […]
via Bing News